BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023 Read more about BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs Read more about Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
Pfizer and BioNTech announce agreement between Pfizer and the Japanese government to provide additional COVID-19 Vaccine Doses for the 2023 Autumn Special Vaccination Program Read more about Pfizer and BioNTech announce agreement between Pfizer and the Japanese government to provide additional COVID-19 Vaccine Doses for the 2023 Autumn Special Vaccination Program
Statement on Katalin Karikó and Drew Weissman awarded the Nobel Prize in Medicine 2023 Read more about Statement on Katalin Karikó and Drew Weissman awarded the Nobel Prize in Medicine 2023
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine Read more about Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission Read more about BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine Read more about Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union Read more about Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer Read more about BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
